Peptide Research

SLU-PP-332: The "Exercise Mimetic" That Is Not a Peptide

SLU-PP-332 gets sold as a peptide and is not one. It is a small molecule that activates a family of nuclear receptors, and the mouse data behind it are real but early.

Peptide Library Editorial · September 19, 2026 · 3 min read

SLU-PP-332: The "Exercise Mimetic" That Is Not a Peptide — Peptide Library research guide

SLU-PP-332 is not a peptide. It is a small synthetic molecule that activates the estrogen-related receptors — ERRα, ERRβ and ERRγ — a family of nuclear receptors involved in mitochondrial biogenesis and oxidative metabolism.

It is sold in the same catalogues as peptides and routinely described as one. The chemistry says otherwise, and the difference matters for how it behaves.

Not an approved drug. SLU-PP-332 has no approved human indication in the US, EU, or UK and no established human dose. It is sold for laboratory research only, and nothing here is dosing guidance.

What ERR receptors do

Despite the name, estrogen-related receptors are not oestrogen receptors and do not bind oestrogen. They are orphan nuclear receptors that regulate genes involved in mitochondrial biogenesis, fatty acid oxidation, and oxidative muscle metabolism.

Those are the same programmes that endurance exercise activates, which is where the "exercise mimetic" framing comes from. It is a description of an overlapping transcriptional programme, not evidence of equivalence.

What the mouse research found

The published work reports that SLU-PP-332 increases oxidative metabolism and endurance capacity in mice, with effects on fat mass, without the animals exercising.

That is a genuine and interesting finding. Three things bound it:

  • It is mice. Metabolic findings in rodents transfer to humans unreliably, and this specific claim has not been tested in people.

  • There is no human trial. No published human dose-ranging or efficacy study exists.

  • The chemistry is still being optimised. Recent work concerns improving the molecule itself, which indicates the starting compound had properties worth changing.

"Chemical optimization" in a 2026 title is informative on its own. A compound still undergoing medicinal-chemistry refinement in the literature is not a finished tool. That is a normal stage of drug discovery and a long way from something with an established human dose.

The exercise mimetic framing

This label attaches to several compounds and deserves the same scepticism each time. MOTS-c gets it on the basis of AMPK activation; SLU-PP-332 gets it for ERR activation.

In both cases the argument is that a compound triggers part of the transcriptional response exercise produces. Exercise also produces mechanical loading, cardiovascular adaptation, and neural changes that no receptor agonist reproduces. Overlapping one pathway is not substitution.

It is a small molecule, with the usual consequences

Not being a peptide means it is not digested by proteases and not cleared like one, so oral activity is plausible in a way it is not for peptides. It also means none of the reconstitution arithmetic applies.

It joins tesofensine, 5-Amino-1MQ, MK-677 and enclomiphene as compounds sold as peptides that are not — a group large enough now that the category label is doing real damage to understanding.

Frequently asked questions

Is SLU-PP-332 a peptide?

No. It is a small-molecule nuclear receptor agonist with no amino acid chain.

Does it replace exercise?

No published human evidence supports that. The mouse data show effects on oxidative metabolism; exercise does considerably more than activate one transcriptional programme.

Are ERR receptors oestrogen receptors?

No. They are structurally related orphan receptors that do not bind oestrogen. The name reflects sequence similarity, not function.

Research and educational use only. Peptide Library is an independent research and comparison platform and does not sell peptides. Nothing here is medical advice, dosing guidance, or a recommendation to administer any substance to a person or an animal. Consult a licensed clinician for anything concerning human health.

Sources

  1. 1. Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling — International Journal of Biological Macromolecules (2026) Source PubMed

Author

Peptide Library Editorial

Editorial content from Peptide Library. Research and educational use only. Not medical advice.

Related peptides

Research smarter with Peptide Library.

Compare peptides, review vendor data, and use research calculators in one place.

Explore the Library

Research and educational use only. Not medical advice. Peptide Library does not sell peptides.